New opportunities for field research on the pathogenesis and treatment of Lassa fever

被引:131
作者
Khan, Sheik Humarr [1 ,2 ]
Goba, Augustine [1 ,2 ]
Chu, May [3 ]
Roth, Cathy [3 ]
Healing, Tim [3 ]
Marx, Arthur [3 ]
Fair, Joseph [1 ,4 ]
Guttieri, Mary C. [4 ]
Ferro, Philip [4 ]
Imes, Tiffany [1 ]
Monagin, Corina [1 ]
Garry, Robert F. [1 ]
Bausch, Daniel G. [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA
[2] Kenema Govt Hosp, Minist Hlth & Sanitat, Kenema, Sierra Leone
[3] WHO, CH-1211 Geneva, Switzerland
[4] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
关键词
Lassa virus; Lassa fever; Arenavirus; viral hemorrhagic fever; West Africa; antiviral therapy; ribavirin; pathogenesis;
D O I
10.1016/j.antiviral.2007.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Unlike many viral hemorrhagic fevers (VHFs), Lassa fever (LF) is not a rare disease that emerges only as sporadic cases or in outbreak form. Although surveillance is inadequate to determine the true incidence, up to 300,000 infections and 5000 deaths from LF are estimated to occur yearly. The highest incidence is in the "Mano River Union (MRU) countries" of Sierra Leone, Liberia, and Guinea. Although civil unrest in this region over the past two decades has impeded capacity building and research, new-found peace in recent years presents new opportunities. In 2004, the Mano River Union Lassa Fever Network (MRU LFN) was established to assist NIRU countries in the development of national and regional surveillance, diagnosis, treatment, control, and prevention of LF. Here, we review the present literature on treatment and pathogenesis of LF and outline priorities for future research in the field made possible by the improved research capacity of the MRU LFN. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 115
页数:13
相关论文
共 114 条
[31]   Early blood profiles of virus infection in a monkey model for lassa fever [J].
Djavani, Mahmoud M. ;
Crasta, Oswald. R. ;
Zapata, Juan Carlos ;
Fei, Zhangjun ;
Folkerts, Otto ;
Sobral, Bruno ;
Swindells, Mark ;
Bryant, Joseph ;
Davis, Harry ;
Pauza, C. David ;
Lukashevich, Igor S. ;
Hammamieh, Rasha ;
Jett, Marti ;
Salvato, Maria S. .
JOURNAL OF VIROLOGY, 2007, 81 (15) :7960-7973
[32]  
Enria DA, 2006, TROPICAL INFECT DIS, P734
[33]   Lassa virus-infected rodents in refugee camps in Guinea: A looming threat to public health in a politically unstable region [J].
Fair, Joseph ;
Jentes, Emily ;
Inapogui, Alphonse ;
Kourouma, Kerfella ;
Goba, Agustine ;
Bah, Alpha ;
Tounkara, Michel ;
Coulibaly, Mamadi ;
Garry, Robert F. ;
Bausch, Daniel G. .
VECTOR-BORNE AND ZOONOTIC DISEASES, 2007, 7 (02) :167-171
[34]   Effects of anticoagulant strategies on activation of inflammation and coagulation [J].
Feistritzer, Clemens ;
Wiedermann, Christian J. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) :855-870
[35]   Alterations in NF-κB and RBP-Jκ by arenavirus infection of macrophages in vitro and in vivo [J].
Fennewald, SM ;
Aronson, JF ;
Zhang, L ;
Herzog, NK .
JOURNAL OF VIROLOGY, 2002, 76 (03) :1154-1162
[36]   Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa [J].
Fichet-Calvet, Elisabeth ;
Lecompte, Emilie ;
Koivogui, Lamine ;
Soropogui, Barre ;
Dore, Amadou ;
Kourouma, Fode ;
Sylla, Oumar ;
Daffis, Stephane ;
Koulemou, Kekoura ;
Ter Meulen, Jan .
VECTOR-BORNE AND ZOONOTIC DISEASES, 2007, 7 (02) :119-128
[37]   HEMATOLOGIC DYSFUNCTION IN LASSA FEVER [J].
FISHERHOCH, S ;
MCCORMICK, JB ;
SASSO, D ;
CRAVEN, RB .
JOURNAL OF MEDICAL VIROLOGY, 1988, 26 (02) :127-135
[38]  
FISHERHOCH SP, 1985, LANCET, V2, P1227
[39]   UNEXPECTED ADVERSE REACTIONS DURING A CLINICAL-TRIAL IN RURAL WEST AFRICA [J].
FISHERHOCH, SP ;
GBORIE, S ;
PARKER, L ;
HUGGINS, J .
ANTIVIRAL RESEARCH, 1992, 19 (02) :139-147
[40]   REVIEW OF CASES OF NOSOCOMIAL LASSA FEVER IN NIGERIA - THE HIGH PRICE OF POOR MEDICAL-PRACTICE [J].
FISHERHOCH, SP ;
TOMORI, O ;
NASIDI, A ;
PEREZORONOZ, GI ;
FAKILE, Y ;
HUTWAGNER, L ;
MCCORMICK, JB .
BRITISH MEDICAL JOURNAL, 1995, 311 (7009) :857-859